[1]杜梦阳,袁晋青.对比剂诱导的急性肾损伤研究现状[J].心血管病学进展,2019,(8):1087-1090.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.004]
　DU Mengyang,YUAN Jinqing.DU Mengyang,YUAN Jinqing[J].Advances in Cardiovascular Diseases,2019,(8):1087-1090.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.004]
点击复制

对比剂诱导的急性肾损伤研究现状()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年8期
页码:
1087-1090
栏目:
综述
出版日期:
2019-11-25

文章信息/Info

Title:
DU Mengyang,YUAN Jinqing
作者:
杜梦阳; 袁晋青
(中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院,北京 100037)
Author(s):
DU Mengyang; YUAN Jinqing
（Fuwai Hospital, National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences,Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100037,China）
关键词:
对比剂; 急性肾损伤; 造影剂肾病
Keywords:
Contrast;  Acute kidney injury;  Contrast-induced nephropathy
DOI:
10.16806/j.cnki.issn.1004-3934.2019.08.004
摘要:
对比剂诱导的急性肾损伤是一种心血管介入领域常见的医源性问题，常合并近期及远期的死亡率增加，甚至可能加速发展为肾功能不全。很多研究最终发现谨慎选择患者、水化、应用新型对比剂、减少对比剂用量是预防对比剂诱导的急性肾损伤最好的方法。现对这一领域的研究现状进行综述。
Abstract:
Contrast-induced acute kidney injury is a common iatrogenic problem in the field of cardiovascular intervention,often combined with an increase in short-term and long-term mortality, and may even accelerate the development of renal insufficiency. Many studies have finally found that careful selection of patients,hydration,application of new contrast agents,and reduction of contrast agents are the best ways to prevent contrast-induced acute kidney injury.The current research status in this field is reviewed in this article.

参考文献/References:

[1] McCullough PA, Choi JP, Feghali GA,et al. Contrast-induced acute kidney injury[J]. J Am Coll Cardiol,2016,68(13):1465-1473.

[2] Sadeghi HM,Stone GW,Grines CLJ,et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction[J]. Circulation,2003,108(22):2769-2775.
[3] Marenzi G,Lauri G,Assanelli E,et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction[J]. J Am Coll Cardiol,2004,44(9):1780-1785.
[4] Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology[J]. Am J Roentgenol, 2003, 181(6):1463-1471.
[5] Centola M,Lucreziotti S,Salerno-Uriarte D,et al. A comparison between two different de?nitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneuos coronary intervention[J]. Int J Cardiol,2016,210:4-9.
[6] Louie EK,Al-Sadir J,Emmanouel D,et al. Quantitative effects of osmotic diuresis following angiographic contrast administration[J]. Cathet Cardiovasc Diagn,1986,12(4):235-239.
[7] Tumlin J,Stacul F,Adam A,et al. Contrast-induced nephropathy:clinical insights and practical guidance –A report from the CIN consensus working panel[J]. Am J Cardiol,2006, 98(6A):2K-4K.
[8] Rauch D,Drescher P,Pereira FJ,et al. Comparison of iodinated contrast media-induced renal vasoconstriction in human,rabbit,dog,and pig arteries[J]. Invest Radiol,1997,32:315-319.[9]Moreau JF,Droz D,Noel LH,et al. Tubular nephrotoxicity of water-soluble iodinated contrast media[J]. Invest Radiol,1980,15:S54-S60.
[10]Sendeski M,Patzak A, Pallone TL,et al. Iodixanol,constriction of medullary descending vasa recta,and risk for contrast medium-induced ephropathy[J]. Radiology,2009,251(3):697-704.
[11] 赵健斌,吴登轩,陈世群,等. 对比剂诱导急性肾损伤的机制与预防策略[J]. 国际心血管病杂志,2016,43(5):280-282.
[12] Narula A,Mehran R,Weisz G,et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy[J]. Eur Heart J,2014,35(23):1533-1540.
[13] Manske CL,Sprafka JM,Strony JT,et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography[J]. Am J Med,1990,89:615-620.
[14] Jurado-Román A,Hernández-Hernández F,García-Tejada J,et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention[J]. Am J Cardiol,2015,115:1174-1178.
[15] Khwaja A. KDIGO clinical practice guideline for acute kidney injury[J]. Nephron Clin Pract,2012,120(4):c179-c184.
[16] Solomon R,Gordon P,Manoukian SV,et al. Randomized trial of bicarbonate or saline study for the prevention of contrast-induced nephropathy in patients with CKD[J]. Clin J Am Soc Nephrol,2015,10(9):1519-1524.
[17] Hiremath S,Akbari A,Shabana?W,et al. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence[J]. PLoS One,2013,8(3):e60009.
[18]Marenzi G,Lauri G,Assanelli E,et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction[J]. J Am Coll Cardiol,2004,44(12):1780-1785.
[19] Putzu A,Boscolo Berto M,Belletti A,et al. Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures: a systematic review and meta-analysis of randomized trials[J]. JACC Cardiovasc Interv,2017,10:355-363.
[20] Solomon R,Gordon P,Manoukian SV,et al. Randomized trial of bicarbonate or saline study for the prevention of contrast-induced nephropathy in patients with CKD[J]. Clin J Am Soc Nephrol,2015,10:1519-1524.
[21] Ali-Hassan-Sayegh S,Mirhosseini SJ,Rahimizadeh E,et al. Current status of sodium bicarbonate in coronary angiography: an updated comprehensive meta-analysis and systematic review[J]. Cardiol Res Pract,2015,2015:690308.
[22] Subramaniam RM,Suarez-Cuervo C,Wilson RF,et al. Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis[J]. Ann Intern Med,2016,164:406-416.
[23] Xu R,Tao A,Bai Y,et al. Effectiveness of N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis of randomized controlled trials[J]. J Am Heart Assoc,2016,5:pii:e003968.
[24] Feng Y,Huang X,Li L,et al. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy:a meta-analysis[J]. Nephrology (Carlton),2018,23(6):530-538.[25] 高照,黄奕君,许晋川. 造影剂肾病防治的研究进展[J]. 心血管病学进展,2018,39(3):501-505.

相似文献/References:

[1]郑晓雪 季福绥.急性冠脉综合征患者发生急性肾损伤的临床进展[J].心血管病学进展,2019,(5):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
　ZHENG Xiaoxue,JI Fusui.Acute Kidney Injury in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(8):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
[2]李祎 刘德敏.儿童对比剂肾病的研究进展[J].心血管病学进展,2021,(8):725.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.013]
　LI Yi,LIU Demin.Contrast Induced Acute Kidney Injury In Children[J].Advances in Cardiovascular Diseases,2021,(8):725.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.013]

备注/Memo

备注/Memo:
通讯作者：袁晋青，E-mail：jqyuanfw@126.com 收稿日期：2019-03-23
更新日期/Last Update: 2020-01-10